Several Questions About Prostate-Specific Antigen and Salvage Radiotherapy After Radical Prostatectomy Reply

被引:0
|
作者
Tilki, Derya [1 ,2 ,3 ]
Chen, Ming-Hui [4 ]
D'Amico, Anthony V. [5 ,6 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[3] Koc Univ Hosp, Dept Urol, Istanbul, Turkiye
[4] Univ Connecticut, Dept Stat, Storrs, CT USA
[5] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.23.00845
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Artificial Prostate-Specific Antigen Persistence After Radical Prostatectomy
    Poyet, Cedric
    Hof, Danielle
    Sulser, Tullio
    Muentener, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : E62 - E63
  • [22] URINARY PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMY
    TAKAYAMA, TK
    VESSELLA, RL
    BRAWER, MK
    TRUE, LD
    NOTEBOOM, J
    LANGE, PH
    JOURNAL OF UROLOGY, 1994, 151 (01): : 82 - 87
  • [23] Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
    Tilki, Derya
    Chen, Ming-Hui
    Wu, Jing
    Huland, Hartwig
    Graefen, Markus
    Mohamad, Osama
    Cowan, Janet E.
    Feng, Felix Y.
    Carroll, Peter R.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13) : 2428 - +
  • [24] The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer
    Bartkowiak, Detlef
    Siegmann, Alessandra
    Boehmer, Dirk
    Budach, Volker
    Wiegel, Thomas
    BJU INTERNATIONAL, 2019, 124 (05) : 785 - 791
  • [25] Salvage radiotherapy for rising prostate specific antigen after radical prostatectomy for prostate cancer: Dose response analysis
    Buskirk, S. J.
    Pisansky, T. M.
    Schild, S. E.
    Macdonald, O. K.
    Wong, W. W.
    Kozelsky, T. F.
    Heckman, M. G.
    Crook, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S322 - S322
  • [26] Salvage Radiation Therapy for Increasing Prostate-Specific Antigen After Radical Prostatectomy: Who, When, and How?
    Fossati, Nicola
    Cozzarini, Cesare
    Fiorino, Claudio
    Gandaglia, Giorgio
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 469 - +
  • [27] Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy
    Martini, Alberto
    Fossati, Nicola
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    Boeri, Luca
    Bossi, Alberto
    Di Muzio, Nadia
    Cozzarini, Cesare
    Chiorda, Barbara Noris
    Gandaglia, Giorgio
    Robesti, Daniele
    Bartkowiak, Detlef
    Boehmer, Dirk
    Shariat, Shahrokh F.
    Goldner, Gregor
    Battaglia, Antonino
    Joniau, Steven
    Berghen, Charlien
    De Meerleer, Gert
    Fonteyne, Valerie
    Ost, Piet
    Van Poppel, Hein
    Montorsi, Francesco
    Wiegel, Thomas
    Briganti, Alberto
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (02): : 301 - 304
  • [28] Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
    Umezawa, Rei
    Ariga, Hisanori
    Ogawa, Yoshihiro
    Jingu, Keiichi
    Matsushita, Haruo
    Takeda, Ken
    Fujimoto, Keisuke
    Sakayauchi, Toru
    Sugawara, Toshiyuki
    Kubozono, Masaki
    Narazaki, Kakutaro
    Shimizu, Eiji
    Takai, Yoshihiro
    Yamada, Shogo
    RADIATION ONCOLOGY, 2011, 6
  • [29] Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy
    Pearse, Maria
    Choo, Richard
    Danjoux, Cyril
    Gardner, Sandra
    Morton, Gerard
    Szumacher, Ewa
    Lorlaw, Andrew
    Cheung, Patrick
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 792 - 798
  • [30] Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
    Bulychkin, P., V
    Tkachev, S., I
    Matveev, V. B.
    Nazarenko, A., V
    ONKOUROLOGIYA, 2019, 15 (02): : 66 - 72